Lianxiang Luo

4.0k total citations · 1 hit paper
138 papers, 2.5k citations indexed

About

Lianxiang Luo is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Lianxiang Luo has authored 138 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Molecular Biology, 60 papers in Pulmonary and Respiratory Medicine and 45 papers in Cancer Research. Recurrent topics in Lianxiang Luo's work include Ferroptosis and cancer prognosis (52 papers), RNA modifications and cancer (27 papers) and Cancer-related molecular mechanisms research (22 papers). Lianxiang Luo is often cited by papers focused on Ferroptosis and cancer prognosis (52 papers), RNA modifications and cancer (27 papers) and Cancer-related molecular mechanisms research (22 papers). Lianxiang Luo collaborates with scholars based in China, United States and Macao. Lianxiang Luo's co-authors include Xiaoling Li, Shasha He, Liyan Deng, Riming Huang, Fangfang Huang, Hui Luo, Weizhen Zhang, Yuge Huang, Kaifeng Liu and Liao Cui and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Agricultural and Food Chemistry and Scientific Reports.

In The Last Decade

Lianxiang Luo

132 papers receiving 2.5k citations

Hit Papers

Molecular mechanisms of f... 2022 2026 2023 2024 2022 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Molecular mechanisms of ferroptosis and relevance to inflammation
    2022 161 citations Liyan Deng, Shasha He et al. Inflammation Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lianxiang Luo China 27 1.3k 766 675 293 279 138 2.5k
Tinghong Ye China 38 1.9k 1.5× 548 0.7× 445 0.7× 468 1.6× 683 2.4× 126 4.1k
Cun Liu China 27 988 0.8× 288 0.4× 550 0.8× 246 0.8× 318 1.1× 103 1.9k
Chih‐Pin Chuu Taiwan 32 1.5k 1.2× 539 0.7× 575 0.9× 235 0.8× 511 1.8× 100 2.8k
Marek Samec Slovakia 31 1.4k 1.0× 248 0.3× 675 1.0× 162 0.6× 420 1.5× 68 2.8k
Sung‐Kwon Moon South Korea 30 1.5k 1.1× 194 0.3× 479 0.7× 304 1.0× 314 1.1× 98 3.1k
Qiuhua Li China 23 1.0k 0.8× 703 0.9× 248 0.4× 310 1.1× 789 2.8× 80 2.4k
Ghulam Jilany Khan China 24 1.2k 0.9× 172 0.2× 295 0.4× 224 0.8× 297 1.1× 76 2.8k
Yong Lin United States 29 2.0k 1.5× 336 0.4× 819 1.2× 586 2.0× 628 2.3× 67 3.7k
Karol Kajo Slovakia 25 1.0k 0.8× 318 0.4× 499 0.7× 142 0.5× 499 1.8× 134 2.6k

Countries citing papers authored by Lianxiang Luo

Since Specialization
Citations

This map shows the geographic impact of Lianxiang Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lianxiang Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lianxiang Luo more than expected).

Fields of papers citing papers by Lianxiang Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lianxiang Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lianxiang Luo. The network helps show where Lianxiang Luo may publish in the future.

Co-authorship network of co-authors of Lianxiang Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Lianxiang Luo. A scholar is included among the top collaborators of Lianxiang Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lianxiang Luo. Lianxiang Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Jiaqi, et al.. (2025). Food-derived DPP4 inhibitors: Drug discovery based on high-throughput virtual screening and deep learning. Food Chemistry. 477. 143505–143505. 1 indexed citations
2.
Zhang, Juanjuan, Wentao Dong, Baoling Huang, et al.. (2024). Nickel-catalyzed directed hydrodefluorination by using water as a hydride source. Journal of Catalysis. 439. 115754–115754. 2 indexed citations
3.
Yan, Fangfang, et al.. (2024). Targeting ferroptosis in autoimmune diseases: Mechanisms and therapeutic prospects. Autoimmunity Reviews. 23(11). 103640–103640. 14 indexed citations
4.
Deng, Liyan, et al.. (2024). Exploring the ferroptosis-related gene lipocalin 2 as a potential biomarker for sepsis-induced acute respiratory distress syndrome based on machine learning. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(4). 167101–167101. 9 indexed citations
5.
Yan, Fangfang, et al.. (2024). Integration of transcriptomics and metabolomics identify biomarkers of aberrant lipid metabolism in ulcerative colitis. International Immunopharmacology. 131. 111865–111865. 5 indexed citations
6.
Cao, Peng, et al.. (2024). Development of novel ALOX15 inhibitors combining dual machine learning filtering and fragment substitution optimisation approaches, molecular docking and dynamic simulation methods. Journal of Enzyme Inhibition and Medicinal Chemistry. 39(1). 2301756–2301756. 4 indexed citations
7.
Leung, Elaine Lai‐Han, et al.. (2024). Ferroptosis-Modulating Natural Products for Targeting Inflammation-Related Diseases: Challenges and Opportunities in Manipulating Redox Signaling. Antioxidants and Redox Signaling. 41(13-15). 976–991. 2 indexed citations
8.
Wang, Qian, Xin Liu, Jin Su Song, et al.. (2024). Ginsenoside Rb1 targets to HO-1 to improve sepsis by inhibiting ferroptosis. Free Radical Biology and Medicine. 226. 13–28. 9 indexed citations
9.
Li, Huizhen, et al.. (2024). Asiatic acid induces lung cancer toxicity by triggering SRC-mediated ferroptosis. Toxicology and Applied Pharmacology. 492. 117097–117097. 1 indexed citations
10.
He, Shasha, Liyan Deng, Yuhong Guo, et al.. (2024). Identification of RRM2 as a key ferroptosis-related gene in sepsis. Inflammation Research. 73(3). 459–473. 2 indexed citations
11.
Feng, Senling, Yuting Li, Hongliang Huang, et al.. (2023). Isoorientin reverses lung cancer drug resistance by promoting ferroptosis via the SIRT6/Nrf2/GPX4 signaling pathway. European Journal of Pharmacology. 954. 175853–175853. 34 indexed citations
12.
Lin, Xian, Jian Chen, Cheng Tao, et al.. (2023). Osthole regulates N6‐methyladenosine‐modified TGM2 to inhibit the progression of rheumatoid arthritis and associated interstitial lung disease. SHILAP Revista de lepidopterología. 4(2). e219–e219. 22 indexed citations
13.
Luo, Lianxiang, et al.. (2023). mPGES-1 Inhibitor Discovery Based on Computer-Aided Screening: Pharmacophore Models, Molecular Docking, ADMET, and MD Simulations. Molecules. 28(16). 6059–6059. 4 indexed citations
14.
Wu, Shanshan, et al.. (2023). Ferroptosis-Related lncRNAs Act as Novel Prognostic Biomarkers in the Gastric Adenocarcinoma Microenvironment, Immunotherapy, and Chemotherapy. Oxidative Medicine and Cellular Longevity. 2023. 1–28. 4 indexed citations
15.
Wang, Fangfang, Meng Zhang, Meng Yuan, et al.. (2023). A novel sorbicillinoid compound as a potent anti‐inflammation agent through inducing NLRP3 protein degradation. British Journal of Pharmacology. 180(15). 1930–1948. 8 indexed citations
16.
Huang, Fangfang, Suzhou Zhang, Xiaoling Li, et al.. (2022). STAT3-mediated ferroptosis is involved in ulcerative colitis. Free Radical Biology and Medicine. 188. 375–385. 73 indexed citations
17.
Luo, Lianxiang, et al.. (2021). SLC2A5 Correlated with Immune Infiltration: A Candidate Diagnostic and Prognostic Biomarker for Lung Adenocarcinoma. Journal of Immunology Research. 2021. 1–18. 2 indexed citations
18.
Cai, Jian, Chunmei Chen, Yanhui Tan, et al.. (2021). Bioactive Polyketide and Diketopiperazine Derivatives from the Mangrove-Sediment-Derived Fungus Aspergillus sp. SCSIO41407. Molecules. 26(16). 4851–4851. 15 indexed citations
19.
20.
Cai, Bingna, et al.. (2021). Structural characterization, and in vitro immunostimulatory and antitumor activity of an acid polysaccharide from Spirulina platensis. International Journal of Biological Macromolecules. 196. 46–53. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tinghong Ye Breakdown of academic impact, for papers by Cun Liu Breakdown of academic impact, for papers by Chih‐Pin Chuu Breakdown of academic impact, for papers by Marek Samec Breakdown of academic impact, for papers by Sung‐Kwon Moon Breakdown of academic impact, for papers by Qiuhua Li Breakdown of academic impact, for papers by Ghulam Jilany Khan Breakdown of academic impact, for papers by Yong Lin Breakdown of academic impact, for papers by Karol Kajo
Rankless by CCL
2026